N/A
N=46
Continuous And Pulsed Ultrasound Treatments On Carpal Tunnel Syndrome
Carpal Tunnel Syndrome
Bottom Line
View on ClinicalTrials.gov: NCT02054247 ↗Enrolled (actual)
46
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcome: Primary: Change From Baseline in Symptom Severity With Symptom Severity Scale — 23.06; 22.06; 19.66 units on a scale — p=0.442
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- ultrasound (Device); pulsed ultrasound (Device); placebo ultrasound (Device)
- Age
- Pediatric, Adult, Older Adult
- Sex
- Female
- Sponsor
- Eskisehir Osmangazi University
- Primary completion
- Jun 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in Symptom Severity With Symptom Severity Scale |
23.06; 22.06; 19.66 | 0.442 |
| SECONDARY Change From Baseline in Pain With Visual Analogue Scale |
4.40; 2.68; 3.53 | 0.083 |
| SECONDARY Change From Baseline in Functional Status With Functional Status Scale |
18.8; 19.31; 14.2 | 0.125 |
| SECONDARY Changes From Baseline Nervus Medianus Motor Conduction Velocity |
54.26; 55.68; 57.91 | 0.146 |
Summary
The aim of this placebo-controlled study was to evaluate the effects of pulsed and continuous ultrasound treatments combined with splint therapy on patients with mild and moderate idiopathic carpal tunnel syndrome
Eligibility Criteria
Inclusion Criteria
- Mild or moderate idiopathic carpal tunnel syndrome (without thenar atrophy or spontaneous activity on electrophysiological examination of the abductor pollicis brevis (APB) muscle)
Exclusion Criteria
- Secondary entrapment neuropathies
- Cervical radiculopathy
- Systemic diseases with increased risk of the carpal tunnel syndrome
- Gained surgical relief of the syndrome
- Treated with ultrasound for the syndrome
- A history of steroid injections into the carpal tunnel and of physical therapy within the last 3 months
- Patients with either thenar atrophy or spontaneous activity (fibrillation potentials and positive sharp waves) on electrophysiological examination
Data sourced from ClinicalTrials.gov (NCT02054247). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.